Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

250
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

316
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

528
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
528
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

283
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
283
Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First look at evaluation of serum angiopoietin-like 4 levels in bladder cancer: A pilot study.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same author

Cystic Fibrosis (CF) and Modulators Based Therapy (CFTR) in oral and salivary perspectives: A single center cross-sectional study.

Respiratory medicine·2025
Same author

Stakeholder perceptions of biodiversity in urban residential areas.

Journal of environmental management·2025
Same author

The multidirectional assessment of moderate caloric restriction and metformin treatment in obese patients.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2024
Same author

Soluble receptor for advanced glycation end products (sRAGE) correlates with obesity-related parameters, and it is not easy to be modified by moderate caloric restriction in obese humans.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023
Same author

Pain as a mediator in the temperament-alexithymia relationship in individuals suffering from rheumatoid arthritis.

European review for medical and pharmacological sciences·2022

Related Experiment Video

Updated: Feb 28, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.1K

Simple obesity and renal function.

D Sikorska1,2, M Grzymislawska3, M Roszak4,5

  • 1Department of Pathophysiology, Poznan University of Medical Sciences, Poznan, Poland. dorotasikorska@ump.edu.pl.

Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|June 15, 2017
PubMed
Summary
This summary is machine-generated.

Obesity significantly raises chronic kidney disease risk, even without other conditions. Early detection via glomerular filtration rate and albuminuria monitoring is crucial, and dietary changes can help manage the disease.

More Related Videos

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

2.6K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

784

Related Experiment Videos

Last Updated: Feb 28, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.1K
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

2.6K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

784

Area of Science:

  • Nephrology
  • Metabolic Disorders

Background:

  • Obesity is increasingly linked to chronic kidney disease (CKD) risk, independent of common comorbidities like diabetes and hypertension.
  • Obesity-related glomerulopathy presents early with glomerular hypertrophy, sometimes with secondary focal segmental glomerulosclerosis.
  • Diagnosis is challenging as kidney biopsies are rarely performed during these early stages.

Purpose of the Study:

  • To review recent advancements in understanding the pathophysiology of kidney dysfunction in obesity.
  • To explore the utility of monitoring glomerular filtration rate (GFR) and albuminuria for early CKD detection in obese individuals.
  • To discuss the therapeutic benefits of dietary interventions for obesity-associated kidney disease.

Main Methods:

  • Literature review of recent studies on obesity-related kidney disease.
  • Analysis of diagnostic markers including GFR and albuminuria.
  • Evaluation of evidence for dietary interventions in managing kidney dysfunction.

Main Results:

  • Obesity contributes to CKD through mechanisms beyond traditional risk factors.
  • Regular monitoring of GFR and albuminuria shows promise for early diagnosis.
  • Moderate dietary restriction can positively impact the progression of obesity-related kidney disease.

Conclusions:

  • Obesity is an independent risk factor for CKD.
  • Early detection strategies focusing on GFR and albuminuria are essential.
  • Dietary modification is a viable approach to manage and potentially slow the progression of obesity-associated kidney dysfunction.